Calyxt Announces Strategic Hires in Business Development and Manufacturing
Continued investment in key hires to strategically position Company for future growth and scale ROSEVILLE, Minn., April 26, 2022 /PRNewswire/ — Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, yesterday welcomed the second of two director-level hires in areas critical to the continued advancement of the Company’s key technology and business development goals. The first…
